首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 製藥 > 製藥企業 > 醫藥品市場的區塊化:投資、策略及導入
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

醫藥品市場的區塊化:投資、策略及導入

Pharmaceutical Market Segmentation: Spending, Strategy and Implementation

出版商 Cutting Edge Information
出版日期 2006年07月 商品編碼 41836
內容資訊 英文 132 Pages
價格
本報告書已不再販售

本報告已在2011年12月09日停止出版。

簡介

革新性企業由於投資範圍涵蓋整體顧客區塊並且針對各區塊進行個別的行銷活動,因此才能有如此卓越的成果表現。

提供製藥產業創新且實用的調查與顧問服務的調查公司 Cutting Edge Information (總公司:美國北卡羅來那州),調查與分析醫藥品市場的區塊化,並有系統地出版綜合報告書 "Pharmaceutical Market Segmentation: Spending, Strategy and Implementation"

此報告書使用許多的圖表,除了說明醫藥品產業首位企業的市場區塊化手法與策略,也探討市場開拓所需的手續與基準等。此報告書的概略架構如下所示。

摘要

  • 企業檔案與治療領域
  • 方法論與定義
  • 醫藥品市場區塊化:成功的6項原則

市場區塊化的預算、架構及人員配置

  • 品牌市場的區塊化預算
  • 市場區塊化架構
  • 市場區塊化的人員配置
  • 小規模製藥企業及生物科技市場的區塊化預算與架構
  • 歐洲市場的區塊化預算與架構

市場區塊化策略

  • 市場區塊化的方法
  • 市場區塊化的時機
  • 市場區塊化的未來
  • 小規模製藥企業及生物科技市場區塊化的方法
  • 歐洲市場的區塊化方法

市場區塊化策略的實施與評論

  • 醫師區塊化的實施
  • 市場區塊化評論
  • 消費者的區塊化

圖表

封面圖片:
表紙

目錄

Abstract

Cutting Edge Information has developed this study to research pharmaceutical market segmentation and how companies use it to their advantage. Pharmaceutical Market Segmentation examines market segmentation budgets, structures, staffing, strategies and implementation to teach you how enact new or improve existing segmentation plans. From leadership to spending to sales team implementation, this report details some of the industry' s top companies' segmentation strategies.

Cutting Edge Information' s report Pharmaceutical Market Segmentation analyzes market segmentation metrics and strategies from some of the industry' s top companies to provide all the steps necessary to improve market segmentation and offer purchasers benchmarks for excellence.

The report makes its case with market segmentation metrics and techniques in three chapters:

  • Market Segmentation Budgets, Structure and Staffing - Details brand-level overall market segmentation budgets, as well as physician and consumer segmentation spending. Also examines participants' market segmentation structures and staffing.
  • Market Segmentation Strategy - Examines the various techniques for segmenting markets and provides real companies' rankings for and reactions to each technique.
  • Implementing and Reviewing Market Segmentation Strategies - Explains how top companies convey segmentation strategy and importance to their sales forces. Explores how these same companies ensure that they have the full buy-in of the sales force and that segmentation is working. Finally, the chapter discusses how often and in what way companies review their segmentation strategies after a product is launched.

Charts and Graphics

EXECUTIVE SUMMARY

  • Figure E.1: Self-Grading Overall Segmentation Performance
  • Figure E.2: Average Product' s Market Segmentation Budget
  • Figure E.3: Top Spenders' Average Product' s Market Segmentation Budgets
  • Figure E.4: Grading Segmentation Techniques
  • Figure E.5: Grading Behavioral Segmentation
  • Figure E.6: Annual Reviews and Changes to Segmentation Strategies

MARKET SEGMENTATION BUDGETS, STRUCTURES AND STAFFING

Brand Market Segmentation Budgets

  • Figure 1.1: Average Products' Market Segmentation Budgets
  • Figure 1.2: Percent of Average Brands' Budgets Earmarked for Physician Segmentation
  • Figure 1.3: Average Products' Physician Segmentation Budgets
  • Figure 1.4: Percent of Physician Segmentation Budgets Spent on Outsourced Activities
  • Figure 1.5: Average Products' Consumer Segmentation Budgets
  • Figure 1.6: Company D' s Market Segmentation Budgeting Process
  • Figure 1.7: Company F' s Market Segmentation Budgeting Process
  • Figure 1.8: Company I' s Market Segmentation Budgeting Process
  • Figure 1.9: Percent of Total Segmentation Project Time Spent on Each Step
  • Figure 1.10: Percent of Spending by Segmentation Project Step
  • Figure 1.11: Outsourcing by Project Step
  • Figure 1.12: Outsourcing for Questionnaire Development
  • Figure 1.13: Outsourcing for Data Collection
  • Figure 1.14: Outsourcing for Data Cleansing
  • Figure 1.15: Outsourcing for Data Analysis
  • Figure 1.16: Outsourcing for Segmenting Customer Groups
  • Figure 1.17: Outsourcing for Segmentation Implementation

Market Segmentation Structure

  • Table 1.1: Brand Level Market Segmentation Leadership
  • Table 1.2: Market Segmentation Task Responsibilities
  • Figure 1.18: Outsourcing Percentage by Project Step
  • Figure 1.19: Company D' s Market Segmentation Process: Setting Strategy
  • Figure 1.20: Company D' s Market Segmentation Process: Performing the Work
  • Figure 1.21: Company D' s Market Segmentation Process: Final Approval
  • Figure 1.22: Company D: Communicating Segmentation to the Sales Force
  • Figure 1.23: Company L' s Market Segmentation Process
  • Figure 1.24: Company F' s New Product Market Segmentation Process
  • Figure 1.25: Company F' s In-Line Product Market Segmentation Process
  • Figure 1.26: Average FTEs in Each Major Department Dedicated to Market Segmentation

Market Segmentation Staffing

  • Figure 1.27: Brand Team FTEs Dedicated to Market Segmentation
  • Figure 1.28: Market Research FTEs Dedicated to Market Segmentation
  • Figure 1.29: Sales FTEs Dedicated to Market Segmentation
  • Figure 1.30: Consumer Marketing FTEs Dedicated to Market Segmentation
  • Figure 1.31: Company B FTEs Dedicated to Market Segmentation
  • Figure 1.32: Company E FTEs Dedicated to Market Segmentation
  • Figure 1.33: Company F FTEs Dedicated to Market Segmentation

Small Pharma/Biotech Market Segmentation Budget and Structure Snapshot

  • Figure 1.34: Small Pharma/Biotech Average Brands' Overall Market

Segmentation Budgets

  • Figure 1.35: Small Pharma/Biotech Average Brands' Physician Segmentation Budgets
  • Table 1.3: Small Pharma/Biotech Brand Level Market Segmentation Leadership
  • Table 1.4: Small Pharma/Biotech Market Segmentation Task Responsibilities

European Market Segmentation Budget and Structure Snapshot

  • Figure 1.36: European Average Brands' Overall Market Segmentation Budgets
  • Figure 1.37: European Average Brands' Physician Segmentation Budgets
  • Table 1.5: European Brand Level Market Segmentation Leadership
  • Table 1.6: European Market Segmentation Task Responsibilities

MARKET SEGMENTATION STRATEGIES

Methods of Market Segmentation

  • Figure 2.1: Usage by Segmentation Type
  • Figure 2.2: Grading Segmentation Techniques
  • Figure 2.3: Grading Behavioral Segmentation
  • Figure 2.4: Grading Attitudinal Segmentation
  • Figure 2.5: Grading Volumetric Segmentation
  • Figure 2.6: Grading Psychographic Segmentation
  • Figure 2.7: Grading Demographic Segmentation
  • Figure 2.8: Grading Geographic Segmentation
  • Figure 2.9: Grading Longitudinal Segmentation

Timing Market Segmentation

  • Figure 2.10: Self-Grading of Overall Segmentation Performance

The Future of Market Segmentation

  • Table 2.1: Latent Class Segmentation Versus Traditional Methods

Small Pharma/Biotech Market Segmentation Methodology Snapshot

  • Figure 2.11: Small Pharma/Biotech Companies' Usage of Segmentation Methods
  • Figure 2.12: Small Pharma/Biotechs' Grading of Segmentation Techniques

European Market Segmentation Methodology Snapshot

  • Figure 2.13: European Companies' Usage by Segmentation Method
  • Figure 2.14: European Companies' Grading of Segmentation Techniques

IMPLEMENTING AND REVIEWING MARKET SEGMENTATION STRATEGIES

Implementing Physician Segmentation

  • Figure 3.1: Company D: Communicating Segmentation to the Sales Force
  • Figure 3.2: Company F: Market Research Sells Segmentation
  • Figure 3.3: Company I: Trickle-Down Introduction
  • Figure 3.4: Company U: Sales Force Preparation in the 12 Months Before Launch
  • Figure 3.5: New Rep Training
  • Figure 3.6: Existing Rep Training
  • Figure 3.7: Average Number of Physician Segments Created

Reviewing Market Segmentation

  • Figure 3.8: Times Market Segmentation Reviewed per Year
Back to Top